• Hummingbird Bio raises $19M in Series B round biospectrumasia
    December 09, 2019
    Hummingbird Bioscience, an innovative biotherapeutics company located in Singapore and US, has announced that it has raised $19 million in a Series B financing round.
PharmaSources Customer Service